Literature DB >> 8645243

Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.

G Perides1, R Noring, M S Klempner.   

Abstract

Lyme disease is caused by Borrelia burgdorferi. Human plasminogen and urokinase-type plasminogen activator bind to the surface of the spirochete where plasmin is generated. We have suggested that bound urokinase and plasminogen are utilized by the organism to disseminate. We tested whether the physiological inhibitors of urokinase, plasminogen activator inhibitor-1 and -2 (PAI-1, PAI-2), could regulate the activity of spirochete-bound urokinase. The k(ass) of PAI-1 and PAI-2 for bound urokinase were 1.3 x 10(6) M(-1)s(-1) and 6.9 x 10(4)M(-1)s(-1), respectively, whereas the k(ass) for free urokinase were 7.2 x 10(6) M(-1)s(-1) and 5.3 x 10(5) M(-1)s(-1), respectively. Plasmin associated with the spirochete was not inhibited by alpha2-antiplasmin. These results suggest that PAI-1, PAI-2 and alpha2 antiplasmin would not be efficient regulators of fibrinolytic protease activity on the Borrelial surface and would not pose a barrier to utilization of these enzymes for dissemination in the human host.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645243     DOI: 10.1006/bbrc.1996.0296

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Cerebral sinuvenous thrombosis associated with Lyme neuroborreliosis.

Authors:  Michael Adamaszek; Alexander Heinrich; Andreas Rang; Sönke Langner; Alexander V Khaw
Journal:  J Neurol       Date:  2009-11-26       Impact factor: 4.849

2.  Plasminogen binding and activation at the surface of Helicobacter pylori CCUG 17874.

Authors:  M Pantzar; A Ljungh; T Wadström
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

3.  Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier.

Authors:  Dennis J Grab; George Perides; J Stephen Dumler; Kee Jun Kim; Jinho Park; Yuri V Kim; Olga Nikolskaia; Kyoung Seong Choi; Monique F Stins; Kwang Sik Kim
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Plasmin-coated borrelia Burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix.

Authors:  J L Coleman; E J Roemer; J L Benach
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  Isolation, cloning, and expression of a 70-kilodalton plasminogen binding protein of Borrelia burgdorferi.

Authors:  L T Hu; S D Pratt; G Perides; L Katz; R A Rogers; M S Klempner
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis.

Authors:  J A Gebbia; J C Monco; J L Degen; T H Bugge; J L Benach
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

Review 7.  Lyme Disease Pathogenesis.

Authors:  Jenifer Coburn; Brandon Garcia; Linden T Hu; Mollie W Jewett; Peter Kraiczy; Steven J Norris; Jon Skare
Journal:  Curr Issues Mol Biol       Date:  2020-12-23       Impact factor: 2.081

8.  The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi.

Authors:  Joppe W R Hovius; Maarten F Bijlsma; Gerritje J W van der Windt; W Joost Wiersinga; Bastiaan J D Boukens; Jeroen Coumou; Anneke Oei; Regina de Beer; Alex F de Vos; Cornelis van 't Veer; Alje P van Dam; Penghua Wang; Erol Fikrig; Marcel M Levi; Joris J T H Roelofs; Tom van der Poll
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.